THE CAVE

[milehighbuck]

The price can be judged by the other newly minted cancer vaccines. They range from 3.00 tio 10.00 IIRC. The parent company Accentia was a NASDAQ stock a while back but had to file for bankruptcy protection in November and was delisted down to OTC:BB.

The price of .46 certainly reflects investor anticipation of the FDA approval but that is not even close to the real value of a Lymphoma vaccine. They take cells from individual cancer patients tumors and custom design the "vaccine" to specificly target those cells. Very amazing ! IE: personalized theraputic vaccines.

BVTI shot to 1.50 in July on the positive phase 3 trial news. This thing has a very small float; it moves easily.